 CI, 3%-70%) and shortened
time to ulcer healing,29-31 with a favorable cost-effectiveness31,32 and improved venous symptoms.28,29 MPFF is
used worldwide but is not FDA approved in the United
States. Pentoxifylline was initially developed to treat PAD
and has been used off label in VLUs. It has a powerful
inhibitory effect on cytokine-mediated neutrophil activation,